Home Cart Sign in  
Chemical Structure| 18956-16-6 Chemical Structure| 18956-16-6

Structure of Cardamonin
CAS No.: 18956-16-6

Chemical Structure| 18956-16-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Cardamonin (Cardamomin), a natural flavone isolated from Alpinia katsumadai Hayata, acts as an aryl hydrocarbon receptor (AhR) activator. Cardamonin alleviates inflammatory bowel disease by the inhibition of NLRP3 inflammasome activation via an AhR/Nrf2/NQO1 pathway .

Synonyms: Cardamomin; Alpinetin chalcone

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Cardamonin

CAS No. :18956-16-6
Formula : C16H14O4
M.W : 270.28
SMILES Code : COC1=CC(O)=CC(O)=C1C(=O)C=CC1=CC=CC=C1
Synonyms :
Cardamomin; Alpinetin chalcone
MDL No. :MFCD00238554

Safety of Cardamonin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H312-H332
Precautionary Statements:P280

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MDA-MB-231 cells 20 μM 2, 4, 6 h Cardamonin increased ROS levels in MDA-MB-231 cells PMC6712736
MDA-MB-231 cells 20 μM 3, 6, 12 h Cardamonin enhanced mitochondrial oxidative phosphorylation in MDA-MB-231 cells PMC6712736
MDA-MB-231 cells 20 μM 6 h Cardamonin decreased glucose uptake in MDA-MB-231 cells PMC6712736
RAW 264.7 cells 10, 20, 30 µM 24 h Cardamonin inhibited nitric oxide production in LPS-stimulated RAW 264.7 cells without affecting cell viability. PMC8146383
THP-1 cells 20 µM 24 h Conditioned medium from cardamonin-pre-treated THP-1 cells did not increase the proliferation of HCT116 cells. PMC8146383
Nf1-silenced murine GBM cells 10 and 20 μM 24 and 48 h To evaluate the effect of Cardamonin on NF-κB phosphorylation, results showed that Cardamonin treatment did not reduce NF-κB phosphorylation PMC10645395
THP-1 induced macrophages 10 µM and 20 µM 24 h Cardamonin suppressed M2 polarization of TAMs and downregulated TAM-secreted tumorigenic factors, thereby hindering the pro-tumor function of TAMs on ovarian cancer cells. PMC9278033
SKOV3 and A2780 cells 0, 10, 20, 30, 40, 50 µM 24 h Cardamonin inhibited the cell viability of SKOV3 and A2780 cells in a concentration-dependent manner. PMC9278033
SUM190 10 μM 4 days Cardamonin inhibited the formation of mammosphere-like structures induced by poly(I:C) and suppressed the nuclear translocation of NF-κB and β-catenin. PMC4291491
SUM190 10 μM 4 days Cardamonin inhibited the increase in the CD44high/CD24−/low cell subpopulation induced by poly(I:C). PMC4291491
SUM190 10 μM 4 days Cardamonin inhibited the expression of Oct4, c-Myc, and CD44 induced by poly(I:C). PMC4291491

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
ICR mice Acute pain models Intraperitoneal injection 0.3, 1, 3, 10 mg/kg Single administration To investigate the antinociceptive effects of Cardamonin in acute pain models and its possible mechanisms. The results showed that Cardamonin significantly inhibited acetic acid-induced abdominal writhing and dose-dependently suppressed pain responses induced by PMA and glutamate. PMC7698774
SCID mice SUDHL-4 cell xenograft model intragastric administration 15 mg/kg once per day for 30 days To evaluate the in vivo anti-tumor effect of Cardamonin on RRAGC-mutant lymphoma, results showed that Cardamonin significantly inhibited tumor growth in RagCT90N-mutant SUDHL-4 cells. PMC10521446
Nude mice MDA-MB-231 xenograft model Intraperitoneal injection 3 mg/kg Once daily for four weeks Cardamonin significantly inhibited tumor growth in the MDA-MB-231 xenograft model PMC6712736
C57Bl/6 mice DSS-induced colitis model oral 10 mg/kg, 50 mg/kg daily for 12 days Cardamonin attenuated DSS-induced colitis and reduced the accumulation of inflammatory cells in the colon. PMC8146383
BALB/c nude mice Xenograft model of SKOV3 cells or SKOV3 cells mixed with M2 macrophages Intraperitoneal injection 5 mg/kg and 25 mg/kg Once daily for 15 days Cardamonin significantly inhibited tumor growth and lowered the expression of CD163 and CD206. PMC9278033
Mice CCI-induced neuropathic pain model Intraperitoneal injection 10 mg/kg Single administration Cardamonin significantly upregulated 5-HT1A receptor subtype expression in the brainstem and spinal cord, indicating its antineuropathic effect in CCI-induced neuropathic pain mice. PMC8234694
nude mice SUM190 xenograft model intraperitoneal injection 30 mg/kg every other day for 20 days Cardamonin almost completely abolished the increase in CSCs induced by poly(I:C). PMC4291491

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.70mL

0.74mL

0.37mL

18.50mL

3.70mL

1.85mL

37.00mL

7.40mL

3.70mL

References

 

Historical Records

Categories